B. Riley Securities Initiates Coverage On Corbus Pharmaceuticals With Buy Rating, Announces Price Target of $85
B. Riley Securities Initiates Coverage On Corbus Pharmaceuticals With Buy Rating, Announces Price Target of $85
B. Riley Securities發佈買入評級，Corbus Pharmaceuticals的目標價爲85美元
B. Riley Securities analyst Kalpit Patel initiates coverage on Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy rating and announces Price Target of $85.
B. Riley Securities的分析師Kalpit Patel發起對Corbus Pharmaceuticals（納斯達克股票代碼：CRBP）的買入評級，並宣佈價格目標爲85美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。